A serotonin hypothesis of schizophrenia

Medical Hypotheses

Volumn 80, Issue 6, 2013, Pages 791-794

  Eggers, Arnold E ^a,b  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b KINGS COUNTY HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; DOPAMINE; GLUTAMIC ACID; NEUROLEPTIC AGENT; PHOSPHOLIPASE A2; SEROTONIN; SEROTONIN 2A RECEPTOR;

ANTERIOR CINGULATE; ARTICLE; BRAIN ATROPHY; COGNITIVE DEFECT; CORPUS STRIATUM; DOPAMINE RELEASE; FRONTAL LOBE; GRAY MATTER; HUMAN; NEGATIVE SYNDROME; NERVE CELL PLASTICITY; NUCLEAR MAGNETIC RESONANCE; POSITRON EMISSION TOMOGRAPHY; SCHIZOPHRENIA; SIGNAL TRANSDUCTION;

FRONTAL LOBE; GYRUS CINGULI; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, BIOLOGICAL; PHOSPHOLIPASES A2; PHOSPHOLIPIDS; POSITRON-EMISSION TOMOGRAPHY; RECEPTORS, SEROTONIN, 5-HT2; SCHIZOPHRENIA; SEROTONIN;

EID: 84877142397     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2013.03.013     Document Type: Article

References (35)

1. 2A/2C receptors in response to stress. Med Hypotheses 2012, 79:740-743.
2. Horrobin D.F. The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia. Schizophr Res 1998, 30:193-208.
3. Berger G.E., Smeny S., Amminger P. Bioactive lipids in schizophrenia. Int Rev Schizophr 2006, 18:85-98.
4. Puri B.K., Hirsch S.R., Easton T., Richardson A.J. A volumetric biochemical niacin flush-based index that noninvasively detects fatty acid deficiency in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2002, 26:49-52.
5. Pettegrew J.W., Keshevan M.S., Panchalingam K., et al. Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode drug-naïve schizophrenis. Arch Gen Psychiatry 1991, 48:563-568.
6. Buchsbaum M.S., Ingvar D.H., Kessler R., Waters R.N., Capplletti J., et al. Cerebral glucography with positron tomography. Use in normal subjects and in patients with schizophrenia. Arch Gen Psychiatry 1982, 39:251-259.
7. Yamasue H., Iwanami A., Hirayasu Y., et al. Localized volume reduction in prefrontal, temporolimbic, and paralimbic regions in schizophrenia: an MRI parcellation study. Psychiatric Res Neuroimaging 2004, 131:195-207.
8. Gur R.E., Turetsky B.I., Bilker W.B., Gur R.C. Reduced grey matter volume in schizophrenia. Arch Gen Psychiatry 1999, 56:905-911.
9. Pol H.E.H., Kahn R.S. What happens after the first episode? A review of progressive brain changes in chronically ill patients with schizophrenia. Schizophr Bull 2008, 34:354-366.
10. Lawrie S.M., Whalley H., Kestelman J.N., Abukmeil S.S., Byrne M., et al. Magnetic resonance imaging of brain in people at high risk of developing schizophrenia. Lancet 1999, 353:30-33.
11. Puri B.K. Progressive structural brain changes in schizophrenia. Expert Rev Neurother 2010, 10:33-42.
12. Staal W.G., Pol H.E., Schnack H.G., van Haren N.E.M., Sefert N., Kahn R.S. Structural brain abnormalities in chronic schizophrenia at the extremes of the outcome spectrum. Am J Psychiatry 2001, 158:1140-1142.
13. Harrison P.J. The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain 1999, 122:593-624.
14. Pakkenberg K. Total nerve number in neocortex in neocortex in chronic schizophrenics and controls estimated using optical dissectors. Biol Psychiatry 1993, 34:768-772.
15. Trachtenburg J.T., Chen B.F., Knott G.W., Feng G., Sanes J.R., et al. Long-term in vivo imaging of experience-dependent synaptic plasticity in adult cortex. Nature 2002, 420:788-794.
16. Jones E.G., Pons T.P. Thalamic and brainstem contributions to large-scale plasticity of primate somatosensory cortex. Science 1998, 282:1121-1125.
17. Woods T.M., Popken G.J., Jones E.G. Reduction in volume of the cuneate nucleus in adult monkeys following long-term deafferentation of the upper limb. Soc Neurosci Abstr 1998, 24:1512.
18. Berger B., Trottier S., Verney C., Gaspar P., Alvarez C. Regional and laminar distribution of the dopamine and serotonin innervation in the macaque cerebral cortex: a radioautographic study. J Comp Neurol 1988, 273:99-119.
19. Paus T. Primate anterior cingulate cortex: where motor control, drive and cognition interface. Nature Rev Neurosci 2001, 2:417-424.
20. Gaspar P., Berger B., Febvret A., Vigny A., Henry J.P. Catecholamine innervation of the human cerebral cortex as revealed by comparative immunohistochemistry of tyrosine hydroxylase and dopamine-β-hydroxylase. J Comp Neurol 1989, 279:249-271.
21. Schwartz T.L., Sachdeva S., Stahl S.M. Glutamate neurocircuitry: theoretical underpinnings in schizophrenia. Front Pharmacol 2012, 3:195-205.
22. 2 receptor binding in the anterior cingulate cortex in schizophrenia. Arch Gen Psychiatry 2002, 59:25-30.
23. Buchsbaum M.S., Christian B.T., Lehrer D.S., Narayanan T.K., Shi B., et al. D2/D3 dopamine receptor binding with [F-18]fallypride in thalamus and cortex of patients with schizophrenia. Schizophrenia Res 2006, 85:232-244.
24. 1 dopamine receptor binding in neuroleptic-naïve patients with schizophrenia. Am J Psychiatry 2002, 159:761-767.
25. 1 receptors and working memory in schizophrenia. J Neurosci 2002, 22:3708-3719.
26. 18F]setoperone. Am J Psychiatry 2000, 157:1016-1018.
27. Lieberman J.A., Tollefson G.D., Charles C., Zipursky R., Sharma T., et al. Antipsychotic drug effects on brain morphology in first-episode psychosis. Arch Gen Psychiatry 2005, 62:361-370.
28. 2+ channel antagonist on thalamic relay and local circuit interneurons in a rat model of absence epilepsy. Neuropharmacology 2007, 53:431-446.
29. Martella G., Costa C., Pisani A., Cupini L.M., Bernardi G., Calabresi P. Antiepileptic drugs on calcium currents recorded from cortical and PAG neurons: therapeutic implications for migraine. Cephalalgia 2008, 28:1315-1326.
30. Coulter D.A., Huguenard J.R., Prince D.A. Characterization of ethosuximide reduction of low-threshold calcium current in thalamic neurons. Ann Neurol 1989, 25:582-593.
31. Mosko S.S., Jacobs B.L. Recording of dorsal raphe unit activity in vitro. Neurosci Lett 1976, 2:195-2000.
32. 2+ conductance. Synapse 1987, 1:582-588.
33. + current in neocortical neurons. Epilepsy Res 1998, 32:304-308.
34. +-dependent theta-like rhythmicity in stellate cells of entorhinal cortex layer II. Nature 1989, 342:175-177.
35. Eggers A.E. Redrawing Papez' circuit: a theory about how acute stress becomes chronic and causes disease. Med Hypotheses 2007, 69:852-857.